Effect of dose rate on local control and complications in the reirradiation of head and neck tumors with interstitial iridium-192
Journal Article
·
· International Journal of Radiation Oncology, Biology and Physics; (USA)
- Univ. of Tennessee, Memphis (USA)
Interstitial Iridium-192 was used as the sole treatment for 23 previously irradiated patients with recurrent or second primary malignancy in the head and neck region. Doses used in initial external beam treatment ranged from 50.0 to 72.0 Gy, in daily fractions of 180 to 200 cGy. Retreatment with interstitial implant using the Quimby system delivered total doses between 38.5 and 60 Gy, with hourly dose rates of 30 to 66 cGy. Local control in the implanted volume was seen in 21 of 23 patients at 5 to 34 months post-implant (median 10 months). Dose rate (hourly dose delivered at 0.5 cm beyond the periphery of the implanted tumor volume) did not affect local control, but did have a significant impact on severe complications (soft tissue necrosis and fistulae; p = 0.26). No effect on either local control or complication rate was found for volume of implant, initial external beam radiation dose, time to recurrence, or anatomic site of treatment. These findings suggest that interstitial irradiation is effective treatment for head and neck cancers in previously irradiated sites. Dose rates as low as 32 cGy/hr provided adequate local control, with few long-term complications to date; doses above 42 cGy/hr may be associated with severe and even fatal complications.
- OSTI ID:
- 5669959
- Journal Information:
- International Journal of Radiation Oncology, Biology and Physics; (USA), Journal Name: International Journal of Radiation Oncology, Biology and Physics; (USA) Vol. 17:2; ISSN IOBPD; ISSN 0360-3016
- Country of Publication:
- United States
- Language:
- English
Similar Records
High-dose reirradiation of head and neck cancer with curative intent
Continuous low dose rate brachytherapy with high activity iodine-125 seeds inthe management of meningiomas
Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer
Journal Article
·
Fri Jul 01 00:00:00 EDT 1994
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:86484
Continuous low dose rate brachytherapy with high activity iodine-125 seeds inthe management of meningiomas
Journal Article
·
Thu Jan 14 23:00:00 EST 1993
· International Journal of Radiation Oncology, Biology and Physics; (United States)
·
OSTI ID:6877113
Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer
Journal Article
·
Mon Aug 01 00:00:00 EDT 2005
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:20698504
Related Subjects
550603* -- Medicine-- External Radiation in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
BODY AREAS
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
FRACTIONATED IRRADIATION
HEAD
HEAVY NUCLEI
IMPLANTS
INTERNAL CONVERSION RADIOISOTOPES
IRIDIUM 192
IRIDIUM ISOTOPES
IRRADIATION
ISOMERIC TRANSITION
ISOTOPES
MEDICINE
NECK
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
PATIENTS
RADIATION DOSES
RADIATION SOURCE IMPLANTS
RADIATION SOURCES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
THERAPY
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
BODY
BODY AREAS
DAYS LIVING RADIOISOTOPES
DISEASES
DOSES
ELECTRON CAPTURE RADIOISOTOPES
FRACTIONATED IRRADIATION
HEAD
HEAVY NUCLEI
IMPLANTS
INTERNAL CONVERSION RADIOISOTOPES
IRIDIUM 192
IRIDIUM ISOTOPES
IRRADIATION
ISOMERIC TRANSITION
ISOTOPES
MEDICINE
NECK
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
PATIENTS
RADIATION DOSES
RADIATION SOURCE IMPLANTS
RADIATION SOURCES
RADIOISOTOPES
RADIOLOGY
RADIOTHERAPY
THERAPY